February 1, 2000
Journal Article

Accommodating Protein Flexibility in Computational Drug
Design

Abstract

The need to account for the dynamic behavior of a receptor has long been recognized as a complicating factor in computational drug design. The use of a single, rigid protein structure— usually from a high-quality X-ray crystal structure— still is the standard in most applications (Zheng and Kyle, 1997; Walters et al., 1998). The choice to use a single protein structure is usually based on speed. For example, if a large database of compounds is to be screened for binding affinity, several conformers of each compound will be compared with each protein configuration. Although it is more accurate to use many representative protein configurations, it quickly becomes a very slow process to screen each conformer of each ligand against each protein configuration. It is usually impractical to attempt such prohibitively slow calculations because there is an unfortunate but necessary trade-off between speed and accuracy in computer modeling.

Revised: January 23, 2012 | Published: February 1, 2000

Citation

Carlson H.A., and A. Mccammon. 2000. "Accommodating Protein Flexibility in Computational Drug Design." Molecular Pharmacology 57, no. 2:213-218.